DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Golla K, Bhaskar C, Ahmed F. et al.
A target-specific oral formulation of doxorubicin-protein nanoparticles: Efficacy and safety in hepatocellular cancer.
Journal of Cancer 2013;
4: 644
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.